Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6100413 | Journal of Crohn's and Colitis | 2011 | 4 Pages |
Abstract
We report two cases of Stevens-Johnson syndrome (SJS) associated with the use of sulfasalazine in two ulcerative colitis patients previously tolerant to mesalamine. SJS and toxic epidermal necrolysis (TEN) are very rare adverse cutaneous reactions that can be associated with the use of sulfasalazine. The most severe cases can result in death, and for the others, permanent skin, mucosal or ocular sequelae, which can impair the quality of life in our young IBD patients. Clinicians and patients need to be aware of the signs and symptoms that often precede the appearance of the mucocutaneous lesions in a SJS or TEN, such as fever, influenza-like symptoms, sore throat or burning eyes. For patients with SJS or TEN, immediate withdrawal of the offending medication should be done when blisters or erosions appear in the course of a drug eruption, as this may improve the prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Lydjie Tremblay, Guillaume Pineton de Chambrun, Bénédicte De Vroey, Céline Lavogiez, Emmanuel Delaporte, Jean-Frédéric Colombel, Antoine Cortot,